1. An exosomal strategy for targeting cancer-associated fibroblasts mediated tumors desmoplastic microenvironments.
- Author
-
Xue X, Wang X, Pang M, Yu L, Qian J, Li X, Tian M, Lu C, Xiao C, and Liu Y
- Subjects
- Humans, Animals, Neoplasms drug therapy, Neoplasms metabolism, Neoplasms pathology, Drug Delivery Systems methods, Extracellular Matrix metabolism, Antineoplastic Agents pharmacology, Cancer-Associated Fibroblasts metabolism, Exosomes metabolism, Tumor Microenvironment drug effects
- Abstract
Tumors desmoplastic microenvironments are characterized by abundant stromal cells and extracellular matrix (ECM) deposition. Cancer-associated fibroblasts (CAFs), as the most abundant of all stromal cells, play significant role in mediating microenvironments, which not only remodel ECM to establish unique pathological barriers to hinder drug delivery in desmoplastic tumors, but also talk with immune cells and cancer cells to promote immunosuppression and cancer stem cells-mediated drug resistance. Thus, CAFs mediated desmoplastic microenvironments will be emerging as promising strategy to treat desmoplastic tumors. However, due to the complexity of microenvironments and the heterogeneity of CAFs in such tumors, an effective deliver system should be fully considered when designing the strategy of targeting CAFs mediated microenvironments. Engineered exosomes own powerful intercellular communication, cargoes delivery, penetration and targeted property of desired sites, which endow them with powerful theranostic potential in desmoplastic tumors. Here, we illustrate the significance of CAFs in tumors desmoplastic microenvironments and the theranostic potential of engineered exosomes targeting CAFs mediated desmoplastic microenvironments in next generation personalized nano-drugs development., (© 2024. The Author(s).)
- Published
- 2024
- Full Text
- View/download PDF